643: Transglutaminase 2, a potential biomarker and therapeutic target for meningioma by microarray analysis.

MLA

Huang, Y. C., et al. “643: Transglutaminase 2, a Potential Biomarker and Therapeutic Target for Meningioma by Microarray Analysis.” European Journal of Cancer, vol. 50, July 2014, p. S153. EBSCOhost, https://doi.org/10.1016/S0959-8049(14)50564-3.

APA

Huang, Y. C., Wei, K. C., Chang, C. N., Chen, P. Y., Chen, C. P., Lu, C. S., Wang, H. L., Gutmann, D. H., & Yeh, T. H. (2014). 643: Transglutaminase 2, a potential biomarker and therapeutic target for meningioma by microarray analysis. European Journal of Cancer, 50, S153. https://doi.org/10.1016/S0959-8049(14)50564-3

Chicago

Huang, Y.C., K.C. Wei, C.N. Chang, P.Y. Chen, C.P. Chen, C.S. Lu, H.L. Wang, D.H. Gutmann, and T.H. Yeh. 2014. “643: Transglutaminase 2, a Potential Biomarker and Therapeutic Target for Meningioma by Microarray Analysis.” European Journal of Cancer 50 (July): S153. doi:10.1016/S0959-8049(14)50564-3.